Drug
ECC0509 clinical trials
Also written ECC0509.
- studies test it
- 3
- open now
- 2
- in phase 3
- 0
- first study started
- 2021
Keep track of what changes. Save the ECC0509 studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Development codes
Studies by the year they started
3 studies that test it; most in 2021 (1)
| Year | Studies |
|---|---|
| 2021 | 1 |
| 2025 | 1 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 2
- Phase 2
- 1
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 3 · Other 0
Eccogene (3)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses ECC0509 is read from its arms, and is right about nine times in ten.
Testing it · 3
- DDI Study of ECC0509 With Metformin, Midazolam, and CaffeineNot yet recruitingPhase 1EccogeneNCT07873229Written as ECC0509
- A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor, Alone and in Combination, in Adults With Presumed Metabolic Dysfunction-associated Steatohepatitis (MASH)RecruitingPhase 2EccogeneNCT07288138Written as ECC0509
- FTIH Study of ECC0509 in Healthy VolunteersCompletedPhase 1EccogeneNCT05012423Written as ECC0509